NSW exploration and agreed disposal
Field work continued at Brungle Creek and an agreement was made to dispose of Koonenberry. Completion in August 2021 belongs after the June balance date.
Ausmon’s financial story is exploration funded by share issues, asset disposals and borrowing, not a producing mine’s operating margin. By June 2025, cash was very limited and exploration assets represented most of the balance sheet. Funding access and cash actually held need to be read separately.
Reading the figures: Units are stated above each table or beside the metric. Brackets denote negative amounts. Supported nil is shown as zero; unlike reporting bases remain separately labelled.
Cash held at 30 June.
Includes exploration impairment.
Non-current at June 2025.
Auditor-identified concentration.
The portfolio evolved from NSW gold and base-metal exploration toward ionic-clay rare earth opportunities in South Australia. Ausmon remained an exploration group without product-sales revenue; production, AISC and sales-volume tables would therefore give the wrong impression.
The Koonenberry disposal combined cash and listed shares. Later sales and revaluations of those investments affected both cash and earnings, but the two measures do not move together.
Field work continued at Brungle Creek and an agreement was made to dispose of Koonenberry. Completion in August 2021 belongs after the June balance date.
The disposal delivered cash plus Odin shares. South Australian rare earth applications progressed; the July 2022 licence grants belong to the following financial year.
Four licences were granted in July 2022. Historic-hole testing and low-cost studies prepared the ground for planned drilling rather than establishing mine revenue.
Exploration prioritised Enmore and the Limestone Coast while some other field work paused. The working-capital facility was increased and extended.
A share purchase plan and placement raised fresh equity. Enmore drilling paused after technical difficulties; resumption was planned subject to financing.
The FY2025 operating and investing outflows exceeded financing inflows. Available borrowing capacity helps explain how work could continue, but it is not cash already received. The auditor recorded a material going-concern uncertainty.
A$ million
AI-generated presentation · values from Five-year earnings and cash record; no missing values plotted as zero.
A$ million
AI-generated presentation · values from Five-year earnings and cash record; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Loss after tax | (0.583) | (0.370) | (0.511) | (0.365) | (1.047) |
| Operating cash flow | (0.361) | (0.441) | (0.429) | (0.276) | (0.435) |
| Investing cash flow | (0.727) | (0.156) | (0.269) | (0.332) | (0.384) |
| Financing cash flow | 0.752 | 0.952 | 0.365 | 0.557 | 0.803 |
| Closing cash | 0.055 | 0.410 | 0.078 | 0.026 | 0.011 |
Years ended 30 June; A$ million, rounded. FY2025 closing cash is A$10,968, not A$0.011 in absolute dollars.
Operating cash excludes exploration payments classified as investing.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Exploration cash continued even as the cash buffer narrowed. The FY2025 exploration asset remained substantial after a recorded impairment; its recovery depends on successful project outcomes or sale.
A$ million
AI-generated presentation · values from Cash spent on exploration; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Exploration and evaluation payments | (0.717) | (0.263) | (0.294) | (0.526) | (0.487) |
Investing cash outflows; they are already included in the investing total above.
Changes in capitalised exploration also include accounting adjustments; these payments are not a complete asset roll-forward.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Exploration assets dominated total assets. Current liabilities exceeded current assets in FY2025, while the non-current facility balance increased. The statement therefore shows positive book equity alongside near-term funding dependence.
A$ million
AI-generated presentation · values from Exploration assets dominate the balance sheet; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Capitalised exploration and evaluation | 1.151 | 1.370 | 1.901 | 2.462 | 2.375 |
| Total assets | 1.335 | 2.114 | 2.355 | 2.828 | 2.534 |
| Current assets | 0.104 | 0.674 | 0.385 | 0.285 | 0.079 |
| Current liabilities | 0.228 | 0.267 | 0.499 | 0.361 | 0.263 |
| Total liabilities | 0.353 | 0.512 | 0.506 | 0.965 | 1.203 |
| Total equity | 0.982 | 1.602 | 1.849 | 1.862 | 1.331 |
| Non-current borrowings | 0.125 | 0.240 | 0.000 | 0.450 | 0.940 |
Exploration carrying amounts depend on successful development, exploitation or sale; they are not cash and are not a project valuation.
FY2025 current assets of A$78,696 were below current liabilities of A$262,903. An undrawn facility is separate from both closing cash and debt already drawn.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
The FY2025 facility ceiling was A$1.6m with A$0.66m undrawn at June. July loan notes and the later A$0.975m available balance are subsequent events, not the June position. Conflicting rate wording in the packet is not used to calculate a financing forecast.
A$ million
AI-generated presentation · values from Funding sources and repayments; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Gross share-issue cash | 0.683 | 0.713 | 0.648 | 0.156 | 0.399 |
| Borrowings received | 0.125 | 0.415 | 0.070 | 0.730 | 1.311 |
| Borrowings repaid | 0.000 | (0.300) | (0.310) | (0.280) | (0.821) |
| Borrowing costs paid | (0.016) | (0.018) | (0.029) | (0.049) | (0.087) |
Selected cash lines, not a full reconciliation to financing cash; share costs, treasury transactions and EIP loan repayments also occur.
Shares issued for director fees and employee incentive arrangements are not automatically cash receipts.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
The latest result includes exploration impairment, share-based payments and realised/unrealised investment losses. These are distinct from exploration cash outlays and from the gross proceeds of selling shares in G11 Resources.
A$ million
| Metric | FY2024 | FY2025 |
|---|---|---|
| Loss after tax | (0.365) | (1.047) |
| Interest and other income / (loss) | 0.196 | (0.068) |
| Exploration impairment expense | 0.000 | (0.368) |
| Share-based payment expense | (0.071) | (0.048) |
Selected earnings drivers; this is not an additive bridge to loss.
The income statement and management summary both record FY2025 impairment of A$368,111. A contradictory no-impairment narrative in the packet is not used to erase the charge.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Prepared solely from the existing year-by-year extraction datasets. No raw annual-report body, PDF, new database lookup or financial web research was used. Review is against those stored extractions, not a new independent original-document audit.
The source references in this report identify the public disclosures used and should be read with the associated section, table and reporting-period qualifications. This report paraphrases, organises and compares those disclosures for descriptive and educational purposes rather than reproducing source text.
Copyright and other rights in linked reports, company names, logos and third-party materials remain with their respective owners. MII Research does not claim affiliation with or endorsement by the company covered in this report, the ASX or cited organisations.
This report uses AI actively and extensively for evidence extraction, comparison, organisation, calculation checks, drafting, translation planning and presentation. Material claims received reasonable editorial review against cited public sources; this was not an audit, assurance engagement or independent verification. Limitations in public sources, AI systems and review may leave errors, omissions, inconsistencies or translation, classification and interpretation errors.
Any AI-generated visual accompanying this report must carry an adjacent, visible AI-generated label or caption. Such visuals are illustrative rather than source evidence and do not replace the cited annual-report text, table or section source.
This record is for general descriptive and educational information only. It is not financial-product, investment, legal, tax, technical or other professional advice; it is not a securities recommendation, valuation, target price, offer, solicitation or invitation to buy, sell or hold.
It does not consider any reader’s objectives, financial situation, needs, knowledge, experience or risk tolerance. Independently verify material information against the primary disclosures, obtain appropriate independent professional advice and do not use this record as the sole or primary basis for any decision.
Public sources are used in good faith, but no representation or warranty is made as to accuracy, completeness, reliability, currency or fitness for a particular purpose. To the maximum extent permitted by law, MII Research disclaims liability for direct, indirect, incidental, consequential, opportunity or investment loss arising from use of or reliance on this record; nothing excludes or limits liability that cannot lawfully be excluded or limited.
Report suspected errors to MII Research with the relevant report section and primary-source document and page reference so that the record can be reviewed and corrected where appropriate.